Group CD62L+CCR7-subset (% ± SD) CD62L-CCR7+subset (% ± SD)
HCC 0.76 ± 0.47a 6.44 ± 4.20c
Paracancerous tissue 0.28 ± 0.24b 1.03 ± 0.45
Control 0.83 ± 0.66 0.75 ± 0.72
Note: (a) compared to that of paracancerous tissue group, P<0.05; (b) compared to that of control group, P<0.05; (c) compared to that of paracancerous tissue group and control group, P<0.05.
Table 4: The percentage of CD62L+CCR7- subset and CD62L-CCR7+ subset relative to CD8+CD45RO+Tm detected by FCM.